分枝病変の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)

【英語タイトル】Global Bifurcation Lesions Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

GlobalInfoResearchが出版した調査資料(GIR8100601)・商品コード:GIR8100601
・発行会社(調査会社):GlobalInfoResearch
・発行日:2018年10月3日
・ページ数:122
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:世界
・産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートは、分枝病変の世界市場について調べ、まとめました。種類別セグメントは、1ステント、2ステント等、用途別セグメントは、冠動脈血管、末梢血管等に区分しました。分枝病変の世界市場概観、メーカー動向、メーカー別分枝病変シェア、市場規模推移、市場規模予測、主要地域分析(北米、ヨーロッパ、アジア等)、主要国分析(日本、中国、アメリカ等)データなどの情報が含まれています。
・分枝病変の市場概観
・分枝病変のメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・分枝病変のメーカー別販売動向、市場シェア、市場集中度、競争動向
・分枝病変の世界市場規模
・分枝病変の北米市場分析(アメリカ、カナダ、メキシコ等)
・分枝病変のアメリカ市場規模推移
・分枝病変のカナダ市場規模推移
・分枝病変のメキシコ市場規模推移
・分枝病変のヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・分枝病変のドイツ市場規模推移
・分枝病変のイギリス市場規模推移
・分枝病変のロシア市場規模推移
・分枝病変のアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・分枝病変の日本市場規模推移
・分枝病変の中国市場規模推移
・分枝病変の韓国市場規模推移
・分枝病変のインド市場規模推移
・分枝病変の東南アジア市場規模推移
・分枝病変の南米市場分析(ブラジル、アルゼンチン等)
・分枝病変の中東・アフリカ市場分析(サウジアラビア、UAE、南アフリカ等)
・分枝病変の種類別分析/市場規模推移(1ステント、2ステント)
・分枝病変の用途別分析/市場規模推移(冠動脈血管、末梢血管)
・分枝病変の市場予測(地域別予測、種類別予測、用途別予測)
・分枝病変の販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

A artery narrowing occuring adjacent to,
and/or involving, the origin of a significant side
branch.

Scope of the Report:

This report studies the Bifurcation Lesions market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bifurcation Lesions market by product type and applications/end industries.

North America dominated the bifurcation lesions market in 2016. The region is expected to maintain its dominance during the forecast period. This can be attributed to local presence of major market players, higher disposable income, and favorable reimbursement policies.

The global Bifurcation Lesions market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bifurcation Lesions.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Boston Scientific Corporation

Abbott

Cardinal Health

Medtronic

C. R. Bard, Inc.

Johnson & Johnson Services, Inc.

Spectranetics

Terumo Medical Corporation

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

One-Stent

Two-Stent

Market Segment by Applications, can be divided into

Coronary Vascular

Peripheral Vascular

【レポートの目次】

Table of Contents

1 Bifurcation Lesions Market Overview

1.1 Product Overview and Scope of Bifurcation Lesions

1.2 Classification of Bifurcation Lesions by Types

1.2.1 Global Bifurcation Lesions Revenue Comparison by Types (2017-2023)

1.2.2 Global Bifurcation Lesions Revenue Market Share by Types in 2017

1.2.3 One-Stent

1.2.4 Two-Stent

1.3 Global Bifurcation Lesions Market by Application

1.3.1 Global Bifurcation Lesions Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Coronary Vascular

1.3.3 Peripheral Vascular

1.4 Global Bifurcation Lesions Market by Regions

1.4.1 Global Bifurcation Lesions Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Bifurcation Lesions Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Bifurcation Lesions Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bifurcation Lesions Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Bifurcation Lesions Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bifurcation Lesions Status and Prospect (2013-2023)

1.5 Global Market Size of Bifurcation Lesions (2013-2023)

2 Manufacturers Profiles

2.1 Boston Scientific Corporation

2.1.1 Business Overview

2.1.2 Bifurcation Lesions Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Boston Scientific Corporation Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

2.2 Abbott

2.2.1 Business Overview

2.2.2 Bifurcation Lesions Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Abbott Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

2.3 Cardinal Health

2.3.1 Business Overview

2.3.2 Bifurcation Lesions Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Cardinal Health Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

2.4 Medtronic

2.4.1 Business Overview

2.4.2 Bifurcation Lesions Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Medtronic Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

2.5 C. R. Bard, Inc.

2.5.1 Business Overview

2.5.2 Bifurcation Lesions Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 C. R. Bard, Inc. Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

2.6 Johnson & Johnson Services, Inc.

2.6.1 Business Overview

2.6.2 Bifurcation Lesions Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Johnson & Johnson Services, Inc. Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

2.7 Spectranetics

2.7.1 Business Overview

2.7.2 Bifurcation Lesions Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Spectranetics Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

2.8 Terumo Medical Corporation

2.8.1 Business Overview

2.8.2 Bifurcation Lesions Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Terumo Medical Corporation Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

3 Global Bifurcation Lesions Market Competition, by Players

3.1 Global Bifurcation Lesions Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Bifurcation Lesions Players Market Share

3.2.2 Top 10 Bifurcation Lesions Players Market Share

3.3 Market Competition Trend

4 Global Bifurcation Lesions Market Size by Regions

4.1 Global Bifurcation Lesions Revenue and Market Share by Regions

4.2 North America Bifurcation Lesions Revenue and Growth Rate (2013-2018)

4.3 Europe Bifurcation Lesions Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Bifurcation Lesions Revenue and Growth Rate (2013-2018)

4.5 South America Bifurcation Lesions Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Bifurcation Lesions Revenue and Growth Rate (2013-2018)

5 North America Bifurcation Lesions Revenue by Countries

5.1 North America Bifurcation Lesions Revenue by Countries (2013-2018)

5.2 USA Bifurcation Lesions Revenue and Growth Rate (2013-2018)

5.3 Canada Bifurcation Lesions Revenue and Growth Rate (2013-2018)

5.4 Mexico Bifurcation Lesions Revenue and Growth Rate (2013-2018)

6 Europe Bifurcation Lesions Revenue by Countries

6.1 Europe Bifurcation Lesions Revenue by Countries (2013-2018)

6.2 Germany Bifurcation Lesions Revenue and Growth Rate (2013-2018)

6.3 UK Bifurcation Lesions Revenue and Growth Rate (2013-2018)

6.4 France Bifurcation Lesions Revenue and Growth Rate (2013-2018)

6.5 Russia Bifurcation Lesions Revenue and Growth Rate (2013-2018)

6.6 Italy Bifurcation Lesions Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Bifurcation Lesions Revenue by Countries

7.1 Asia-Pacific Bifurcation Lesions Revenue by Countries (2013-2018)

7.2 China Bifurcation Lesions Revenue and Growth Rate (2013-2018)

7.3 Japan Bifurcation Lesions Revenue and Growth Rate (2013-2018)

7.4 Korea Bifurcation Lesions Revenue and Growth Rate (2013-2018)

7.5 India Bifurcation Lesions Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Bifurcation Lesions Revenue and Growth Rate (2013-2018)

8 South America Bifurcation Lesions Revenue by Countries

8.1 South America Bifurcation Lesions Revenue by Countries (2013-2018)

8.2 Brazil Bifurcation Lesions Revenue and Growth Rate (2013-2018)

8.3 Argentina Bifurcation Lesions Revenue and Growth Rate (2013-2018)

8.4 Colombia Bifurcation Lesions Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Bifurcation Lesions by Countries

9.1 Middle East and Africa Bifurcation Lesions Revenue by Countries (2013-2018)

9.2 Saudi Arabia Bifurcation Lesions Revenue and Growth Rate (2013-2018)

9.3 UAE Bifurcation Lesions Revenue and Growth Rate (2013-2018)

9.4 Egypt Bifurcation Lesions Revenue and Growth Rate (2013-2018)

9.5 Nigeria Bifurcation Lesions Revenue and Growth Rate (2013-2018)

9.6 South Africa Bifurcation Lesions Revenue and Growth Rate (2013-2018)

10 Global Bifurcation Lesions Market Segment by Type

10.1 Global Bifurcation Lesions Revenue and Market Share by Type (2013-2018)

10.2 Global Bifurcation Lesions Market Forecast by Type (2018-2023)

10.3 One-Stent Revenue Growth Rate (2013-2023)

10.4 Two-Stent Revenue Growth Rate (2013-2023)

11 Global Bifurcation Lesions Market Segment by Application

11.1 Global Bifurcation Lesions Revenue Market Share by Application (2013-2018)

11.2 Bifurcation Lesions Market Forecast by Application (2018-2023)

11.3 Coronary Vascular Revenue Growth (2013-2018)

11.4 Peripheral Vascular Revenue Growth (2013-2018)

12 Global Bifurcation Lesions Market Size Forecast (2018-2023)

12.1 Global Bifurcation Lesions Market Size Forecast (2018-2023)

12.2 Global Bifurcation Lesions Market Forecast by Regions (2018-2023)

12.3 North America Bifurcation Lesions Revenue Market Forecast (2018-2023)

12.4 Europe Bifurcation Lesions Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Bifurcation Lesions Revenue Market Forecast (2018-2023)

12.6 South America Bifurcation Lesions Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Bifurcation Lesions Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures



Figure Bifurcation Lesions Picture

Table Product Specifications of Bifurcation Lesions

Table Global Bifurcation Lesions and Revenue (Million USD) Market Split by Product Type

Figure Global Bifurcation Lesions Revenue Market Share by Types in 2017

Figure One-Stent Picture

Figure Two-Stent Picture

Table Global Bifurcation Lesions Revenue (Million USD) by Application (2013-2023)

Figure Bifurcation Lesions Revenue Market Share by Applications in 2017

Figure Coronary Vascular Picture

Figure Peripheral Vascular Picture

Table Global Market Bifurcation Lesions Revenue (Million USD) Comparison by Regions 2013-2023

Figure North America Bifurcation Lesions Revenue (Million USD) and Growth Rate (2013-2023)

Figure Europe Bifurcation Lesions Revenue (Million USD) and Growth Rate (2013-2023)

Figure Asia-Pacific Bifurcation Lesions Revenue (Million USD) and Growth Rate (2013-2023)

Figure South America Bifurcation Lesions Revenue (Million USD) and Growth Rate (2013-2023)

Figure Middle East and Africa Bifurcation Lesions Revenue (Million USD) and Growth Rate (2013-2023)

Figure Global Bifurcation Lesions Revenue (Million USD) and Growth Rate (2013-2023)

Table Boston Scientific Corporation Basic Information, Manufacturing Base and Competitors

Table Boston Scientific Corporation Bifurcation Lesions Type and Applications

Table Boston Scientific Corporation Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

Table Abbott Basic Information, Manufacturing Base and Competitors

Table Abbott Bifurcation Lesions Type and Applications

Table Abbott Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

Table Cardinal Health Basic Information, Manufacturing Base and Competitors

Table Cardinal Health Bifurcation Lesions Type and Applications

Table Cardinal Health Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

Table Medtronic Basic Information, Manufacturing Base and Competitors

Table Medtronic Bifurcation Lesions Type and Applications

Table Medtronic Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

Table C. R. Bard, Inc. Basic Information, Manufacturing Base and Competitors

Table C. R. Bard, Inc. Bifurcation Lesions Type and Applications

Table C. R. Bard, Inc. Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

Table Johnson & Johnson Services, Inc. Basic Information, Manufacturing Base and Competitors

Table Johnson & Johnson Services, Inc. Bifurcation Lesions Type and Applications

Table Johnson & Johnson Services, Inc. Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

Table Spectranetics Basic Information, Manufacturing Base and Competitors

Table Spectranetics Bifurcation Lesions Type and Applications

Table Spectranetics Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

Table Terumo Medical Corporation Basic Information, Manufacturing Base and Competitors

Table Terumo Medical Corporation Bifurcation Lesions Type and Applications

Table Terumo Medical Corporation Bifurcation Lesions Revenue, Gross Margin and Market Share (2016-2017)

Table Global Bifurcation Lesions Revenue (Million USD) by Players (2013-2018)

Table Global Bifurcation Lesions Revenue Share by Players (2013-2018)

Figure Global Bifurcation Lesions Revenue Share by Players in 2016

Figure Global Bifurcation Lesions Revenue Share by Players in 2017

Figure Global Top 5 Players Bifurcation Lesions Revenue Market Share in 2017

Figure Global Top 10 Players Bifurcation Lesions Revenue Market Share in 2017

Figure Global Bifurcation Lesions Revenue (Million USD) and Growth Rate (%) (2013-2018)

Table Global Bifurcation Lesions Revenue (Million USD) by Regions (2013-2018)

Table Global Bifurcation Lesions Revenue Market Share by Regions (2013-2018)

Figure Global Bifurcation Lesions Revenue Market Share by Regions (2013-2018)

Figure Global Bifurcation Lesions Revenue Market Share by Regions in 2017

Figure North America Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Europe Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Asia-Pacific Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure South America Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Middle East and Africa Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Table North America Bifurcation Lesions Revenue by Countries (2013-2018)

Table North America Bifurcation Lesions Revenue Market Share by Countries (2013-2018)

Figure North America Bifurcation Lesions Revenue Market Share by Countries (2013-2018)

Figure North America Bifurcation Lesions Revenue Market Share by Countries in 2017

Figure USA Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Canada Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Mexico Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Table Europe Bifurcation Lesions Revenue (Million USD) by Countries (2013-2018)

Figure Europe Bifurcation Lesions Revenue Market Share by Countries (2013-2018)

Figure Europe Bifurcation Lesions Revenue Market Share by Countries in 2017

Figure Germany Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure UK Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure France Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Russia Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Italy Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Table Asia-Pacific Bifurcation Lesions Revenue (Million USD) by Countries (2013-2018)

Figure Asia-Pacific Bifurcation Lesions Revenue Market Share by Countries (2013-2018)

Figure Asia-Pacific Bifurcation Lesions Revenue Market Share by Countries in 2017

Figure China Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Japan Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Korea Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure India Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Southeast Asia Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Table South America Bifurcation Lesions Revenue by Countries (2013-2018)

Table South America Bifurcation Lesions Revenue Market Share by Countries (2013-2018)

Figure South America Bifurcation Lesions Revenue Market Share by Countries (2013-2018)

Figure South America Bifurcation Lesions Revenue Market Share by Countries in 2017

Figure Brazil Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Argentina Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Colombia Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Table Middle East and Africa Bifurcation Lesions Revenue (Million USD) by Countries (2013-2018)

Table Middle East and Africa Bifurcation Lesions Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Bifurcation Lesions Revenue Market Share by Countries (2013-2018)

Figure Middle East and Africa Bifurcation Lesions Revenue Market Share by Countries in 2017

Figure Saudi Arabia Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure UAE Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Egypt Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure Nigeria Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Figure South Africa Bifurcation Lesions Revenue and Growth Rate (2013-2018)

Table Global Bifurcation Lesions Revenue (Million USD) by Type (2013-2018)

Table Global Bifurcation Lesions Revenue Share by Type (2013-2018)

Figure Global Bifurcation Lesions Revenue Share by Type (2013-2018)

Figure Global Bifurcation Lesions Revenue Share by Type in 2017

Table Global Bifurcation Lesions Revenue Forecast by Type (2018-2023)

Figure Global Bifurcation Lesions Market Share Forecast by Type (2018-2023)

Figure Global One-Stent Revenue Growth Rate (2013-2018)

Figure Global Two-Stent Revenue Growth Rate (2013-2018)

Table Global Bifurcation Lesions Revenue by Application (2013-2018)

Table Global Bifurcation Lesions Revenue Share by Application (2013-2018)

Figure Global Bifurcation Lesions Revenue Share by Application (2013-2018)

Figure Global Bifurcation Lesions Revenue Share by Application in 2017

Table Global Bifurcation Lesions Revenue Forecast by Application (2018-2023)

Figure Global Bifurcation Lesions Market Share Forecast by Application (2018-2023)

Figure Global Coronary Vascular Revenue Growth Rate (2013-2018)

Figure Global Peripheral Vascular Revenue Growth Rate (2013-2018)

Figure Global Bifurcation Lesions Revenue (Million USD) and Growth Rate Forecast (2018 -2023)

Table Global Bifurcation Lesions Revenue (Million USD) Forecast by Regions (2018-2023)

Figure Global Bifurcation Lesions Revenue Market Share Forecast by Regions (2018-2023)

Figure North America Bifurcation Lesions Revenue Market Forecast (2018-2023)

Figure Europe Bifurcation Lesions Revenue Market Forecast (2018-2023)

Figure Asia-Pacific Bifurcation Lesions Revenue Market Forecast (2018-2023)

Figure South America Bifurcation Lesions Revenue Market Forecast (2018-2023)

Figure Middle East and Africa Bifurcation Lesions Revenue Market Forecast (2018-2023)



【レポートのキーワード】

分枝病変、1ステント、2ステント、冠動脈血管、末梢血管

★調査レポート[分枝病変の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)] (コード:GIR8100601)販売に関する免責事項を必ずご確認ください。
★調査レポート[分枝病変の世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2023)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆